Multiple Sclerosis International / 2014 / Article / Tab 5

Research Article

Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy’s Adherence, Hospital Reliability’s Perception, and Services Provided Quality

Table 5

Main factors in the choice of MS Therapy.

Three monthsTwelve months
%%

The drug’s mechanism of action
 Low3613.92510.4
 Medium9436.38635.7
 High12949.813053.9
The drug reduces the relapses
 Low228.5145.8
 Medium7127.47229.9
 High16664.115564.3
The drug slows the disease progression
 Low249.3145.8
 Medium6123.66928.6
 High17467.215865.6
The drug produces fewer antibodies
 Low9335.96928.6
 Medium12548.313455.6
 High4115.83815.8
The drug is well known
 Low4417.04016.6
 Medium11343.610242.3
 High10239.49941.1
The drug has few side effects
 Low2911.2218.7
 Medium9737.511246.5
 High13351.410844.8
The drug improves the MRI
 Low6123.63614.9
 Medium8733.69639.8
 High11142.910945.2
The nurse support for injections
 Low14656.412150.2
 Medium6324.38234.0
 High5019.33815.8
Information support of the company producing the drug
 Low10440.28635.7
 Medium10440.211346.9
 High5119.74217.4
The intramuscular or subcutaneous mode of administration
 Low5521.24719.5
 Medium11845.612250.6
 High8633.27229.9
The ability to let by myself injections
 Low4115.82711.2
 Medium7930.58434.9
 High13953.713053.9
The availability of an autoinjector
 Low7027.04217.4
 Medium7328.27932.8
 High11644.812049.8
How many times a week should I take the drug?
 Low4918.93514.5
 Medium11444.010342.7
 High9637.110342.7
The independence that a treatment can give
 Low3312.72811.6
 Medium7127.48736.1
 High15559.812652.3